CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) - Net Long/Short Value

Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock)
US ˙ NasdaqCM ˙ US16385C1045

CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) - Net Long/Short Value
Halaman ini menyediakan nilai bersih long/short untuk setiap kepemilikan institusional yang dilaporkan melalui pengajuan 13F atau NPORT. Untuk menghitung nilai bersih long/short, kami menambahkan nilai ekuitas ke nilai opsi beli (call option) dan mengurangi nilai opsi jual (put option). Dana yang melaporkan posisi short-borrowed akan melaporkan nilai ekuitas sebagai negatif. Posisi long bersih akan memiliki angka positif di kolom long/short bersih, dan posisi short bersih akan memiliki nilai negatif di kolom tersebut.
Pemilik Nilai Ekuitas
($1000)
Nilai Panggilan
($1000)
Masukkan Nilai
($1000)
Posisi Long/Short Bersih
($1000)
SBI Securities Co., Ltd.
Sphera Funds Management Ltd.
Morgan Stanley
GAMMA Investing LLC
Boothbay Fund Management, Llc
UBS Group AG
Ikarian Capital, LLC
Bnp Paribas Arbitrage, Sa
Orbimed Advisors Llc
Jane Street Group, Llc
Kestra Private Wealth Services, Llc
Rhumbline Advisers
Jpmorgan Chase & Co
Yelin Lapidot Holdings Management Ltd.
Other Listings
DE:2QV
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista